Companion Animal Vaccine Market, By Product Type (Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, Recombinant Vaccine), By Species Type (Canine, Feline, Equine, Avians, and Others) , By Distri
Companion Animal Vaccine Market, By Product Type (Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, Recombinant Vaccine), By Species Type (Canine, Feline, Equine, Avians, and Others) , By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Companion Animal Vaccine Market, By Product Type (Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, Recombinant Vaccine), By Species Type (Canine, Feline, Equine, Avians, and Others) , By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Companion animal vaccinations are those administered to pets (such as dogs and cats) to stimulate their immune responses. Companion animal vaccines, in other words, are used to improve the functioning of the immune system in pets and other animals. Moreover, vaccination can protect companion animals or pets from a variety of diseases, including parvovirus, distemper, leptospirosis, lastomycosis, psittacosis, cat scratch disease, kennel cough, and others. Routine vaccination is a vital part of animal healthcare that ensures companion animals health and well-being. Key players operating in the market are focusing on research and development activities, clinical trials, approval, and the launch of novel vaccines for the treatment of companion animals, which is expected to drive market growth globally.
Market Dynamics
The key players in the vaccine industry are focusing on the development of novel vaccines for prevention against new diseases such as rift valley fever, Bluetongue Virus (BTV), etc. Moreover, major players in the market are focusing on inorganic stratergies such as mergers, acquisitions, and collaboration for vaccine developments for veterinary applications. Increasing investments by governments to support manufacturing and distribution of vaccines is expected to propel market growth for companion animal vaccine. For instane, In June 2022, ARTES Biotechnology, a globally active Research and development company specializing in developing biopharmaceutical production processes, Q-Biologicals NV, a Belgium-based biotechnology company, and instrAction GmbH, a Germany-based multimodal chromatography technology company, partnered to collaborate on the development of a virus-like particle (VLP)-based vaccine platform and stable formulation especially suited for veterinary applications. The intent of “Plurivax” is to develop a stable production platform and an adapted, high-quality process to have an effective and usable integrated best practice suitable for several veterinary vaccines. Thus, the availability of the product in the market, which includes virus-like particles (VLP), is expected to offer opportunities for vaccine manufacturers to develop novel vaccines for veterinary use.
Key features of the study:
This report provides an in-depth analysis of the global companion animal vaccine market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global companion animal vaccine market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva Ltd., Merck & Co. Inc., Virbac, Zoetis Inc., HIPRA, Biogénesis Bago, Ourofino Animal Health, Croda International Plc, KM Biologics, Indian Immunologicals Ltd., Sinovac, Kyoto Biken Laboratories, Inc., HESTER BIOSCIENCES LIMITED, Calier, Bioveta, a.s
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion animal vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal vaccine market
Detailed Segmentation:
Global Companion Animal Vaccine Market , By Product Type:
Attenuated Live Vaccine
Conjugate Vaccine
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
DNA Vaccine
Recombinant Vaccine
Global Companion Animal Vaccine Market , By Species Type:
Canine
Feline
Equine
Avians
Others
Global Companion Animal Vaccine Market , By Distribution channel:
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Others
Global Companion Animal Vaccine Market , By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
Elanco Animal Health Incorporated
Boehringer Ingelheim Gmb
Ceva Ltd.
Merck & Co Inc.
Virbac, Inc.
Zoetis Inc.
HIPRA
Biogénesis Bagó
Ourofino Animal Health.
Croda International Plc
KM Biologics
Indian Immunologicals Ltd.
Sinovac
Kyoto Biken Laboratories, Inc.
HESTER BIOSCIENCES LIMITED
Calier
Bioveta, a.s
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Species Type
Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Product Launches/Approvals
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Companion Animal Vaccine Market – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Companion Animal Vaccine Market, By Product Type, 2018– 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Attenuated Live Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Conjugate Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Inactivated Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Subunit Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Toxoid Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
DNA Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trend
Recombinant Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trend
6. Global Companion Animal Vaccine Market, By Species Type, 2018– 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Canine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Feline
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Equine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Avians
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Segment Trends
7. Global Companion Animal Vaccine Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Veterinary Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Veterinary Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Veterinary Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
8. Global Companion Animal Vaccine Market, By Region, 2018 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Elanco Animal Health Incorporated
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Boehringer Ingelheim GmbH
Ceva Ltd.
Merck & Co. Inc.
Virbac
Zoetis Inc.
HIPRA
Biogénesis Bagó
Ourofino Animal Health.
Croda International Plc
KM Biologics
Indian Immunologicals Ltd.
Sinovac
Kyoto Biken Laboratories, Inc.
HESTER BIOSCIENCES LIMITED
Calier
Bioveta, a.s
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 34 figures on “Global Companion Animal Vaccine Market” – Global forecast to 2030